These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19752507)

  • 1. Inflammation and anti-inflammatory strategies for Alzheimer's disease--a mini-review.
    McNaull BB; Todd S; McGuinness B; Passmore AP
    Gerontology; 2010; 56(1):3-14. PubMed ID: 19752507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
    Koistinaho M; Koistinaho J
    Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of inflammation in Alzheimer's disease.
    Rosenberg PB
    Int Rev Psychiatry; 2005 Dec; 17(6):503-14. PubMed ID: 16401549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease.
    Arnaud L; Robakis NK; Figueiredo-Pereira ME
    Neurodegener Dis; 2006; 3(6):313-9. PubMed ID: 16954650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition.
    Steele M; Stuchbury G; Münch G
    Exp Gerontol; 2007; 42(1-2):28-36. PubMed ID: 16839733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuroimmunomodulation in Alzheimer's disease.
    Maccioni RB; Rojo LE; Fernández JA; Kuljis RO
    Ann N Y Acad Sci; 2009 Feb; 1153():240-6. PubMed ID: 19236346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ; White AR; Bush AI
    FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria and the link between neuroinflammation and neurodegeneration.
    Di Filippo M; Chiasserini D; Tozzi A; Picconi B; Calabresi P
    J Alzheimers Dis; 2010; 20 Suppl 2():S369-79. PubMed ID: 20463396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic changes in Alzheimer's disease.
    Wenk GL
    J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The genetics of Alzheimer's disease].
    Alonso-Vilatela ME; Yescas-Gómez P
    Rev Invest Clin; 1998; 50(2):155-62. PubMed ID: 9658938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
    Lahiri DK; Sambamurti K; Bennett DA
    Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local neuroinflammation and the progression of Alzheimer's disease.
    McGeer PL; McGeer EG
    J Neurovirol; 2002 Dec; 8(6):529-38. PubMed ID: 12476347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-modifying therapies in Alzheimer's disease.
    Salloway S; Mintzer J; Weiner MF; Cummings JL
    Alzheimers Dement; 2008 Mar; 4(2):65-79. PubMed ID: 18631951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology and pathways of Alzheimer's disease with an update on new developments in treatment.
    DeKosky ST
    J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S314-20. PubMed ID: 12801388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs targeting Alzheimer's disease: some things old and some things new.
    Michaelis ML
    J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.